Gerresheimer AG provided earnings guidance for the year 2022. For the year 2022, the company expects organic revenue growth: high single-digit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.4 EUR | -2.64% | +0.25% | +5.35% |
May. 16 | GERRESHEIMER AG : UBS reiterates its Buy rating | ZD |
May. 15 | Schott Pharma falls sharply - 'High dependence on end markets' | DP |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.35% | 3.83B | |
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B |
- Stock Market
- Equities
- GXI Stock
- News Gerresheimer AG
- Gerresheimer AG Provides Earnings Guidance for the Year 2022